Funded by FWF grants F3003 and 24005
In 2006, adipose triglyceride lipase (ATGL) has been identified as key enzyme of mammalian lipolysis, i.e. the hydrolytic cleavage of triglycerides into free fatty acids and diacylglycerols. The lipolytic cascade is completed by the action of hormone sensitive lipase (HSL) and monoglyceride lipase (MGL) which catalyze the breakdown of diacylglycerols and monoacylglycerols, respectively.
ATGL is predominantly expressed in adipose tissues but found to a lesser extent in a variety of other tissues and organs, including kidney, skeletal muscle, and heart. Systemic deletion of the ATGL gene resulted in a phenotype with massive neutral lipid accumulation in multiple tissues and cell types.
In cardiac muscle, ATGL deficiency caused an age-dependent increase of myocyte lipid droplets in number and size. Langendorff perfusion of isolated hearts demonstrated that ATGL-/- mice suffer from prominent systolic and diastolic dysfunction. Left-ventricular developed pressure as function of cardiac preload (Frank Starling relation) was significantly reduced in ATGL deficiency (A). Pharmacological challenge with increasing concentrations of the ß-adrenergic agonist norepinephrine induced a positive inotropic response in WT hearts, while ATGL-/- hearts were much less sensitive (B). (Wölkart et al. BJP 2012; 16:380-89)
NADPH oxidase-mediated superoxide production (measured as gp91ds-tat-inhibited chemiluminescence) was significantly increased in hearts of ATGL-/- mice. In parallel, cardiac protein expression of NADPH oxidase 2 and its cytosolic subunits gp47phox and gp91phox was upregulated indicating that ATGL-/- mice suffer from cardiac oxidative stress. (Schrammel et al. BBA 2013; 1831(11):1600-08)
ContactInstitute of Pharmaceutical Sciences
Fax:+43 (0)316 380 - 9890